- Description of FDA Forms for Export Certification
- Chiron RIBA HCV 3.0 Strip Immunoblot Assay
- A CDC food safety alert regarding a multistate outbreak of Salmonella Senftenberg infections
- CDC Media Telebriefing: Update on 2022 U.S. Monkeypox Investigation
- Blood Pressure and Pulse Donor Eligibility Requirements – Compliance Policy
- Recommendations to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Components
- Compliance Policy Regarding Blood and Blood Component Donation Suitability, Donor Eligibility and Source Plasma Quarantine Hold Requirements
- HIBERIX
- Transcript for Vital Signs Telebriefing: Firearm deaths show historic increase
- FDA's “All-in” Approach to Enterprise Transformation
- Erytype S
- CDC Strengthens Recommendations and Expands Eligibility for COVID-19 Booster Shots
- Update on Children with Acute Hepatitis of Unknown Cause
- Anti-k (Monoclonal) (IgG) (For Further Manufacturing Use)
- LAVIV